Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NA2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,780
Award facts
- Contract value 100% obligated
- $39,779.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,779.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of KESIMPTA 20 mg/0.4 ml auto-injector pens on January 26, 2026, with completion expected by January 27, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. KESIMPTA (ofatumumab) is a monoclonal antibody used primarily for treating multiple sclerosis, reflecting the Defense Logistics Agency Medical Supply Chain's role in providing specialized pharmaceutical products to support military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031. This primary vehicle enables Cencora to supply a broad portfolio of pharmaceutical products, medical devices, and healthcare commodities to support military treatment facilities and veteran healthcare programs globally. AmerisourceBergen's consistent award history through open competition and its established position as a critical pharmaceutical distributor to federal agencies demonstrates its capability to fulfill specialized medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9NA2?
SPE2DR26F9NA2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F9NA2 worth?
The government has obligated $39,780 on SPE2DR26F9NA2.
Is contract SPE2DR26F9NA2 an order under another contract?
Yes. SPE2DR26F9NA2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NA2 competed?
The extent of competition for SPE2DR26F9NA2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award